Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group
Autor: | Nomdedéu, J., Hoyos, M., Carricondo, M., Esteve, J., Bussaglia, E., Estivill, C., Ribera, J.M., Duarte, R., Salamero, O., Gallardo, D., Pedro, C., Aventin, A., Brunet, S., Sierra, J. |
---|---|
Zdroj: | In Leukemia Research August 2012 36(8):990-997 |
Databáze: | ScienceDirect |
Externí odkaz: |